Back

Percutaneous treatment of left main coronary artery disease - temporal trends from large registry and ten-year follow-up. a single centre experience.

25 August 2023 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Patients and lesion subsets Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Emil Julian Dabrowski

Medical University of Bialystok, Bialystok (Poland)

7 More presentations in this session

Presentation thumbnail
Side branch closure in patients undergoing coronary bifurcation stenting with or without side branch predilatation
Professor D. Vassilev (Ruse, BG)
Abstract Slides Video
Presentation thumbnail
Impact of atrial fibrillation on mortality of patients undergoing bifurcation PCI
Professor D. Vassilev (Ruse, BG)
Abstract Slides Video
Presentation thumbnail
A novel scoring system devised by an international large-scale coronary bifurcation registry to guide the optimal choice between the 1- and 2-stent strategy: the BIFURCAT Two-Stent (BTS) score
Assistant Professor P. Oh (Incheon, KR)
Abstract Slides Video
Presentation thumbnail
Double kissing inflation outside the stent versus jailed balloon technique for coronary bifurcation lesions
Doctor H. Yang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Single stent versus two stent strategy in primary PCI for unprotected LM occlusion
Doctor M. Tantawy (Giza, EG)
Abstract Slides Video

Access the full session

Session thumbnail
Patients and lesion subsets

The Event

Event poster

ESC Congress 2023

25 August 2023 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of intravascular imaging on mortality in patients undergoing left main coronary artery PCI. Propensity score matching analysis of the high-volume single centre registry
thumbnail
Congress Presentation
Five-year outcome after unprotected distal left main percutaneous coronary interventions according to complexity defined by DEFINITION criteria
thumbnail
Congress Presentation
Approach to left main disease in 2023: PCI vs. CABG

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources